baber/WOPTO huggingface dataset:
Patent AT-E284538-T1 (AT)
Inventor: HOLTZMAN JORDAN L
IPC: G01N33/53
Filed: 1999-10-29
Granted: 2004-12-15
Abstract: A chaperone protein Q2 and β-amyloid can form a complex. This complex can be detected in a biological sample, such as, for example, tissues or fluids from a mammal. Q2 levels can also be detected in a biological sample. A method for determining the Q2 level in a biological sample and comparing that level to a normal Q2 level can be used to detect, screen, diagnose, or otherwise determine a person's susceptibility to Alzheimer's disease such as, for example, the presence or absence of Alzheimer's disease, of symptoms of this disease, of factors leading to or associated with this disease, of likelihood of developing this disease, and the like. In one embodiment, a decline in Q2 level correlates to an increased likelihood of developing Alzheimer's disease. In another embodiment, a decline in Q2 level correlates to an increase in β-amyloid aggregation. The method may further include screening for an apolipoprotein E genotype, which is associated with Alzheimer's disease.
Patent AT-E246676-T1 (AT)
Inventor: VASUDEVAN JAYASREE
IPC: C07D215/12
Filed: 1999-09-21
Granted: 2003-08-15
Abstract: The present invention relates to compounds of the formula <CHEM> wherein  the two X1 groups are independently selected from H or alkyl of 1 to 6 carbons; the two X2 jointly represent an oxo (=O) or thione (=S) function; W is C(R1)2, whereby R1 is defined as R2, phenyl or naphthyl; R1<*> is methyl, ethyl or n-propyl; R2 is independently H, lower alkyl of 1 to 6 carbons or lower fluoroalkyl of 1 to 6 carbons; R3 is hydrogen or lower alkyl of 1 to 6 carbons; R8 is a methyl or ethyl group; and R14 is H or alkyl of 1 to 10 carbons,  having retinoid-like biological activity. More specifically, the present invention relates to compounds that include a substituted tetrahydroquinoline moiety and a 2,4-pentadienoic acid moiety and have selective activity for retinoid X (RXR) receptors.
Patent ES-2144386-T1 (ES)
Inventor: ANDERSON DIRK M
IPC: C12N15/11
Filed: 1997-12-22
Abstract: Isolated receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response. The receptors are also useful in screening for inhibitors thereof.
Patent CY-1110656-T1 (CY)
Title: Ταχεως εφαρμοσιμο τεμαχιο μαλλιων το οποιο παρεχεται με μια ταινια πλεξης πληρως ενσωματωμενη σε βασικα μαλλια και μεθοδος για στερεωση του
Inventor: GULIKER RICHARD
IPC: A41G3/00
Filed: 2010-06-11
Abstract: Η εφεύρεση αφορά σε ένα ταχέως εφαρμόσιμο τεμάχιο μαλλιών (1) για να επιτυγχάνεται ένα ειδικό αισθητικό αποτέλεσμα όπως λ.χ. ένα χρωματικό αποτέλεσμα ή ένα αποτέλεσμα όγκου μαλλιών που παρέχει μία αξιοσημείωτη υψηλή άνεση χρήσης στον χρήστη. Το τεμάχιο μαλλιών (1) περιλαμβάνει τουλάχιστον ένα λεπτό, μεγάλου πλάτους και επίπεδο τεμάχιο μαλλιών (3) που αποτελείται από έναν αριθμό τριχών (20). Η δέσμη μαλλιών (3, 3', 3") παρέχεται στο ελεύθερο άκρο του με μία ελαφριά και λεπτή επιμήκη ταινία πλέξης (2, 2', 2") κατασκευασμένη από μαλλιά ή από ένα άλλο κατάλληλο υλικό όπως λ.χ. βάμβακα ή ένα συνθετικό υλικό που περιλαμβάνει στοιχεία πλέξης (11) σε τακτά διαστήματα. Αυτή η ταινία πλέξης χαρακτηρίζεται από ανοίγματα σύνδεσης (4, 4', 4", 31) που παρέχονται σε τακτά αμοιβαία διαστήματα. Ένας κατάλληλος αριθμός βασικών μαλλιών (9, 9', 9") μπορεί να διέρχεται διαμέσου των εν λόγω ανοιγμάτων σύνδεσης (4, 4', 4", 31). Ως αποτέλεσμα θα διαμορφώνεται μία προσωρινή, ανθεκτική, εν τούτοις, τελικά εύκολα αφαιρούμενη σύνδεση μεταξύ του τεμαχίου μαλλιών (1) και των βασικών μαλλιών (6), με ένα τέτοιο τρόπο ώστε το τεμάχιο μαλλιών (1) να είναι πάντα επαναχρησιμοποιήσιμο. Επιπλέον η εφεύρεση αφορά σε μία μέθοδο για στερέωση ενός τεμαχίου μαλλιών (1).
Patent CY-1111304-T1 (CY)
Inventor: VESPER MARTIN
IPC: G01D4/00
Filed: 2010-10-25
Abstract: The invention relates to a system for recording amounts of supplied media, comprising a device (10) at the user end for recording the amount of at least one supplied medium at the user end as well as a device (50) at the provider end for acquiring data of the device at the user end, said data being related to the supplied media. At least one meter (20) for the at least one supplied medium is provided at the user end. The device (50) at the provider end and the device (10) at the user end are at least temporarily connected in a communicating manner. The at least one meter (20) is designed to acquire and forward chronologically accurate values of the amount of the at least one supplied medium consumed and/or fed at the user end and is coupled to the device (10) at the user end and/or the device (50) at the provider end via a communication channel (70). A communication module (24) is provided which is coupled to the meter (20), can actively establish a communication with the device (50) at the provider end, and can communicate consumption-related and/or feeding-related data to the device (50) at the provider end.
Patent CY-1111860-T1 (CY)
Inventor: AMBROSINO DONNA
IPC: C12N5/06
Filed: 2011-09-13
Abstract: Antibodies that specifically bind to toxins of  C.difficile,  antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.
Patent CY-1112280-T1 (CY)
Title: Συνθεση πολυδυναμου εμβολιου
Inventor: BOUTRIAU DOMINIQUE
IPC: A61P31/14
Filed: 2012-01-30
Abstract: Περιγράφεται σύνθεση πολυδύναμου εμβολίου που περιλαμβάνει προϊόν σύζευξης καψικού πολυσακχαριδίου του Η. influenzae b μη απορροφηθέντος επί ενός ανοσοενισχυτικού άλατος αργιλίου και δύο ή περισσότερα περαιτέρω βακτηριακά πολυσακχαρίδια. Περιγράφεται επίσης σύνθεση πολυδύναμου εμβολίου που περιλαμβάνει συστατικό ολικού κυττάρου κοκίτη, ατοξίνης τετάνου, ατοξίνης διφθερίτιδας, αντιγόνο επιφανείας Ηπατίτιδας Β, προϊόν σύζευξης καψικού πολυσακχαριδίου του Η. influenzae b και προϊόν σύζευξης καψικού πολυσακχαριδίου του Ν. meningitidis τύπου Α ή C (ή αμφότερα). Περαιτέρω, περιγράφεται σύνθεση πολυδύναμου εμβολίου που περιλαμβάνει συστατικό ολικού κυττάρου κοκίτη, ατοξίνη τετάνου, ατοξίνη διφθερίτιδας και χαμηλή δόση ενός προϊόντος σύζευξης του καψικού πολυσακχαριδίου του Η. influenzae b.
Patent CY-1115743-T1 (CY)
Title: Μεσολαβητης διαχειρισης ταυτοποιησης συνδρομητων για σταθερα/κινητα δικτυα επικοινωνιων
Inventor: TAGG JAMES PETER
IPC: H04W60/00
Filed: 2014-10-29
Abstract: Η παρούσα εφεύρεση σχετίζεται με μία μέθοδο διαχείρισης για την αυτόματη παροχή ενός αναγνωριστικού ταυτοποίησης συνδρομητή δικτύου από ένα κεντρικό server δικτύου προς μία συσκευή συνδρομητή επικοινωνίας, όπου η μέθοδος περιλαμβάνει λήψη ειδοποίησης στον κεντρικό server σχετικά με μία αλλαγή στην τρέχουσα τοποθεσία για την συσκευή συνδρομητή, και προσδιορισμό από την ειδοποίηση αν πρέπει να παρασχεθεί ένα νέο αναγνωριστικό ταυτοποίησης συνδρομητή από τον κεντρικό server. Η μέθοδος περιλαμβάνει περαιτέρω επιλογή ενός αναγνωριστικού ταυτοποίησης συνδρομητή δικτύου με βάση την τρέχουσα τοποθεσία, αν το στάδιο προσδιορισμού έχει προσδιορίσει ότι πρέπει να παρασχεθεί ένα νέο αναγνωριστικό ταυτοποίησης συνδρομητή δικτύου, και εξαγωγή του επιλεγμένου αναγνωριστικού ταυτοποίησης συνδρομητή δικτύου για μετάδοση προς την συσκευή συνδρομητή. Η παρούσα εφεύρεση σχετίζεται επίσης με την διαχείριση της αυτόματης σύνδεσης μιας συσκευής επικοινωνίας συνδρομητή με ένα δίκτυο, όπου μπορούν να χρησιμοποιούνται ένα προτιμητέο δίκτυο και ένα προτιμητέο αναγνωριστικό ταυτοποίησης συνδρομητή δικτύου.
Patent CY-1116316-T1 (CY)
Title: Μεθοδοι και συνθεσεις που περιλαμβανουν υπερμοριακα μορφωματα
Inventor: NICOLAU CLAUDE YVES
IPC: A61K39/385
Filed: 2015-05-25
Abstract: Η παρούσα εφεύρεση περιλαμβάνει νέες συνθέσεις και μεθόδους προκλήσεως υψηλών ανοσολογικών αποκρίσεων, μεγάλης ειδικότητας που αποδίδουν αντισώματα ευαίσθητα από άποψη διαμορφώσεως. Αυτά τα αντισώματα αναγνωρίζουν συγκεκριμένους επιτόπους επί μίας μεγάλης ποικιλίας αντιγόνων που περιλαμβάνουν, αλλά όχι περιοριστικά, αμυλοειδή πρωτεΐνη, πρωτεΐνη πρίον, γλυκοπρωτεΐνη Ρ170· Οι νέες συνθέσεις της εφευρέσεως περιλαμβάνουν υπερμοριακά αντιγονικά μορφώματα που γενικά περιλαμβάνουν μία πεπτιδική αλληλουχία, ομοιοπολικά προσδεδεμένη σε πεγκυλιωμένη λυσίνη καταλήγοντας σε τροποποιημένη και ενισχυμένη πεπτιδική παρουσίαση. Η μοναδική μεθοδολογία τροποποιήσεως της παρούσας εφευρέσεως είναι εφαρμόσιμη σε μία ποικιλία πεπτιδίων και μπορεί τελικά να χρησιμοποιηθεί σε θεραπευτικές συστάσεις και εμβόλια για νόσους και διαταραχές όπως η νόσος Alzheimer.
Patent CY-1118219-T1 (CY)
Title: Διαμορφωτες φαρμακοκινητικων ιδιοτητων θεραπευτικων παραγοντων
Inventor: DESAI MANOJ C
IPC: C07D417/14
Filed: 2016-11-09
Abstract: Η παρούσα εφεύρεση παρέχει μία ένωση Τύπου IV, ή ένα φαρμακευτικώς αποδεκτό άλας, διαλύτωμα, και/ή εστέρα αυτής, συνθέσεις που περιέχουν αυτές τις ενώσεις, θεραπευτικές μεθόδους που περιλαμβάνουν τη χορήγηση αυτών των ενώσεων και θεραπευτικές μεθόδους που περιλαμβάνουν τη χορήγηση αυτών των ενώσεων με τουλάχιστον έναν επιπρόσθετο θεραπευτικό παράγοντα.
Patent CY-1124009-T1 (CY)
Title: Μεθοδος για αποκτηση κωνων παγωτου και προϊοντων εξ' αυτων
Inventor: LÓPEZ OLMO ELENA
IPC: A23G9/28
Filed: 2021-04-09
Abstract: Η εφεύρεση αφορά στην μέθοδο για την παρασκευή ενός κώνου παγωτού σχηματισμένου μέσω μίας γκοφρέτας μορφής κώνου (2) και ενός στρώματος σοκολάτας (3) η οποία είναι διευθετημένη στην εσωτερική όψη και το άνω χείλος της εν λόγω γκοφρέτας (2), και του παγωτού (3) εσωτερικά αυτού. Ένας άλλος στόχος της εφεύρεσης είναι το τρόφιμο προϊόν που λαμβάνεται από την εν λόγω διαδικασία.
Patent CY-1125003-T1 (CY)
Title: Ενωση υποκατεστημενης πιπεριδινης και χρηση αυτης
Inventor: FUJIMOTO TATSUHIKO
IPC: C07D211/36
Filed: 2022-02-22
Abstract: Παρέχεται ένωση υποκατεστημένης πιπεριδίνης με δραστικότητα αγωνιστή υποδοχέα τύπου 2 ορεξίνης. Μια ένωση που αντιπροσωπεύεται από τον τύπο (Ι): όπου κάθε σύμβολο περιγράφεται στην ΠΕΡΙΓΡΑΦΗ, ή άλας αυτής που έχει δραστικότητα αγωνιστή υποδοχέα τύπου 2 ορεξίνης, και που είναι χρήσιμη ως προφυλακτικός ή θεραπευτικός παράγοντας έναντι ναρκοληψίας.
Patent HR-P20120525-T1 (HR)
Inventor: JOHANNES HENDRICUS ALPHONSUS PEETERS
IPC: B29C70/86
Filed: 2012-06-21
Abstract: Ploča, kojoj su površine ploče razmaknute jedna u odnosu na drugu i koja ima obrub koji ograničava površine ploče i koja ploča ima niz paralelno postavljenih, izduženih središnjih elemenata (1, 1´, 1˝, …), kao i trake od materijala (2, 2´, 2˝, …), od kojih traka svaka ima predio koji je smješten između svakog od dva susjedna središnja elementa, i najmanje jedan predio koji se prostire duž jedne od površina ploče, naznačen time što se svaki od predjela trake od materijala, koji se prostire duž površina ploče, pruža preko više središnjih elemenata. Patent sadrži još 14 patentnih zahtjeva.
Patent SI-2330197-T1 (SI)
Title: Antagonistic selective binding agents of osteoprotegerin binding protein
Inventor: DESHPANDE RAJENDRA V
IPC: C12N15/00
Filed: 2001-02-23
Abstract: Selective binding agents of osteoprotegerin binding protein (OPGbp) are provided by the invention. More particularly, the invention provides for antibodies and antigen binding domains which selectively bind to OPGbp and may be used to prevent or treat conditions relating to loss of bone mass. Nucleic acid molecules encoding said antibodies and antigen binding domains, and expression vectors and host cells for the production of same are also provided.
Patent SI-1446537-T1 (SI)
Title: Dividing wall element for room partitions and the like with a filling of heat insulating material, especially mineral wool
Inventor: ROYAR JURGEN
IPC: E04B1/62
Filed: 2002-11-14
Abstract: In a dividing wall element for room partitions the filling of heat insulating material between the outer skins (2, 3) arranged at a certain distance from each other is structured into several insulating layers (4, 5, 6) that are differently specified as far as their heat insulation, sound absorption and/or elastic properties are concerned.
Patent SI-1432576-T1 (SI)
Title: Security paper
Inventor: BOHM MICHAEL
IPC: B42D25/29
Filed: 2002-09-26
Abstract: The invention relates to documents of value, such as bank notes, checks, passports, ID cards or the like, with increased fitness for circulation, to a security paper for producing them, and to a method for producing said security paper and such documents of value.
Patent SI-1663909-T1 (SI)
Title: Liquid accelerator
Inventor: ANGELSKAR TERJE
IPC: C04B22/06
Filed: 2004-08-18
Abstract: To provide a liquid accelerator which excels in accelerating effect and which also excels in storage stability at low temperature and inhibitory effect of alkali-aggregation reaction. A liquid accelerator composed of a fluoride-containing aqueous aluminum salt which is obtained through the reaction of aluminum sulfate and hydrofluoric acid, aluminum hydroxide, and one or more kinds of lithium salts selected from the group consisting of lithium hydroxides, lithium carbonates, and lithium sulfates.
Patent SI-2072151-T1 (SI)
Title: Gravity sifter
Inventor: KOHL ERICH
IPC: B07B4/00
Filed: 2008-10-28
Abstract: The separator has a canal-like section (14) including a transporting unit (18) transported from an input to a grading region (10) along heavy and light particles (22, 24) to be classified. A closure unit (26) is arranged in and/or on the canal-like section. The closure unit is perpendicularly moved towards a transporting direction and arranged in such a manner to overlie with a section of a transporting material. The closure unit is provided with a cylindrical body (28) and a circular piston ring, and is made of steel.
Patent SI-2164516-T1 (SI)
Title: Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins
Inventor: WELS WINFRIED S
IPC: A61K39/395
Filed: 2008-07-10
Abstract: Object matter of the invention is an optimized DNA sequence encoding the scFv(FRP5) antibody fragment. This novel sequence prevents the generation of the undesired byproduct in the context of an scFv(FRP5)-ETA fusion protein, and possibly also other bacterially expressed scFv(FRP5)-containing fusion proteins. The DNA sequence of the scFv(FRP5) domain of scFv(FRP5)-ETA was modified by exchanging a distinct codon, thereby preventing an otherwise possible internal start of protein translation.
Patent TR-200803529-T1 (TR)
Title: Bir sondaj deliğinin dairesel hacmi içindeki basıncın kontrol edilmesi.
Inventor: HERMES ROBERT E
IPC: E21B33/13
Filed: 2006-11-16
Abstract: Bir sondaj deliği içinde bir koruma borusu sisteminin dairesel hacmi içindeki sıvının en azından bir kısmının bir ikinci sıvı ile değiştirilmesi amaçlı bir proses tarif edilir. İkinci sıvı, hacim içindeki sıvı ısıtılmakta içen dairesel hacim içindeki basıncın kontrolü için bir önlem 10 sağlayacak şekilde önceden seçilir
Patent TR-200904007-T1 (TR)
Title: Konnektör serbest bırakıldıktan sonra kablonun hasar görmesini önlemeye yönelik bir kablo geri çekme düzeneği için yöntemler ve aygıt.
Inventor: STUEHRENBERG JUSTIN C
IPC: H02G11/00
Filed: 2007-12-19
Abstract: Bir öğenin bir araçtan serbest bırakılmasının ardından, bir kablo konnektörüne eşlenmiş bir bağlama kordonundaki gevşekliği gidermeye yönelik yöntemler ve aygıt. Bir düzenlemede, kablo gen çekme düzeneği gevşekliği, rüzgar kuvvetleri tarafından hırpalanan konnektörden kaynaklanabilecek olası hasarı azaltmak üzere, öğenin bir uçaktan serbest bırakılmasından sonra gidermektedir.
Patent TR-201006774-T1 (TR)
Title: Tuğla ve seramik cephe kaplama görünümlü alüminyum dış cephe yapılanması.
Inventor: SARAYLI MURAT
IPC: E04F13/12
Filed: 2008-11-25
Abstract: Buluş, yapıların dış cephelerine uygulanmak üzere tuğla ve seramik cephe kaplama görünümlü, panel (10), bağlantı parçası (20) ihtiva eden, bahsedilen panelin (10) üst kısmında formlandınlmış bir kanat (11), bir girinti (12), girinfi (12) ile dik açı oluşturacak şekilde formlandınlmış bir dikme (12.1) bahsedilen panel (10) alt kısmında panele (10) dik oluşturulmuş 1. kol (13), l.kola (13) dik oluşturulmuş 1. basamak (14) ve 1. basamağa (14) dik oluşturulmuş 2. basamak (16) ve 2. basamak (16) ucunda oluşturulmuş topuz (17) içeren alüminyum dış cephe yapılanması (1) ile ilgilidir.
Patent DE-3750758-T2 (DE)
Inventor: BABCOCK WALTER C
IPC: C08G77/38
Filed: 1987-07-22
Granted: 1995-03-16
Abstract: Novel semiperimeable membranes and thin film composite (TFC) gas separation membranes useful in the separation of oxygen, nitrogen, hydrogen, water vapor, methane, carbon dioxide, hydrogen sulfide, lower hydrocarbons, and other gases are disclosed. The novel semipermeable membranes comprise the polycondensation reaction product of two complementary polyfunctional compounds, each having at least two functional groups that are mutually reactive in a condensation polymerization reaction, and at least one of which is selected from siloxanes, alkoxsilyls and aryloxysilyls. The TFC membrane comprises a microporous polymeric support, the surface of which has the novel semipermeable film formed thereon, preferably by interfacial polymerization.
Patent DE-3782026-T2 (DE)
Inventor: MCMICHAEL JAMES W
IPC: C25B9/23
Filed: 1987-12-10
Granted: 1993-02-18
Abstract: The invention is a membrane/electrode structure comprising: an ion exchange membrane having a plurality of islands of catalytically active particles bonded to at least a first face of the membrane, wherein said islands have a diameter or width less than about 1 centimeter and wherein less than 75 percent of the membrane surface is covered with said catalytically active particles.
Patent DE-3782255-T2 (DE)
Inventor: AMER MOH SAMIR
IPC: A61K31/785
Filed: 1987-12-14
Granted: 1993-04-22
Abstract: Orally ingestible compositions for reduction of blood cholesterol levels comprising cholestyramine and as deodorant material a water-soluble carbohydrate syrup such as high fructose corn syrup or a liquid alcohol polyol humectant such as glycerine. The components are blended to form a deodorized powder which may be added to water to form a beverage or mixed with an additional carbohydrate material such as polydextrose to form a unitary orally ingestible product such as a wafer.
Patent DE-3855505-T2 (DE)
Inventor: MEGISON DONALD R
IPC: A61F5/44
Filed: 1988-05-13
Granted: 1997-01-30
Abstract: An absorbent pad having a densification pattern comprising relatively low density tuft regions (28) which are separated and surrounded by channels (30). The channels further comprise storage regions (37) and transport regions (39) wherein one of said storage regions or said transport regions separate and surround the other of said storage regions or said transport regions. The transport regions have a density greater than the density of the storage regions which, in turn, have a density greater than the tuft regions.
Patent DE-3856166-T2 (DE)
Inventor: MORISHIMA HAJIME
IPC: C07D265/30
Filed: 1988-09-02
Granted: 1998-08-06
Abstract: An N-acylamino acid derivative of the formula: <CHEM> wherein each of R<1>, R<2>, R<4> and R<6> is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl or a monocyclic or bicyclic heterocyclic group containing from 1 to 4 hetero atoms; each of R<3> and R<5> is hydrogen or lower alkyl; A is -CH(OH)-(CH2)qR<7> wherein R<7> is hydrogen, lower alkyl, cycloalkyl, cyloalkylalkyl, aryl, aralkyl, a monocyclic or bicyclic heterocyclic group containing from 1 to 4 hetero atoms or -E-R<1><0> wherein E is -S(O)i- wherein i is 0, 1 or 2, oxygen, -NR<1><1>- wherein R<1><1> is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl, or <CHEM> wherein each of R<1><2> and R<1><3> is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl, and R<1><0> is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl or a monocyclic or bicyclic heterocyclic group containing from 1 to 4 hetero atoms provided that when R<1><0> is hydrogen, i is 0, and q is an integer of from 0 to 5; or -CH2-CHR<8>-CO-R<9> wherein R<8> is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl or a monocyclic or bicyclic heterocyclic group containig from 1 to 4 hetero atoms, and R<9> is hydroxyl, -OX wherein X is alkyl, aryl, lower alkoxycarbonyloxyalkyl or 1-phthalidyl, or -N(Y<1>)(Y<2>) wherein each of Y<1> and Y<2> is hydrogen, lower alkyl, aryl, aralkyl or cycloalkyl, or Y<1> and Y<2> form together with the adjacent nitrogen atom a 5- or 6-membered heterocyclic group which may contain a further hetero atom; m is 0, 1 or 2; and n is an integer of from 1 to 5, provided that when R<1> is hydrogen, m is 0; or a salt thereof, which is useful as hypotensive drugs.
Patent DE-3872090-T2 (DE)
Inventor: THURIES EDMOND
IPC: H01H33/95
Filed: 1988-07-28
Granted: 1992-12-03
Abstract: A high- or medium-tension compressed gas circuit breaker taking circuit-breaking energy from the arc, the circuit breaker being of the type comprising: a fixed assembly including main contacts (8a) and arc contacts (21a); a moving assembly including main contacts (26) and arc contacts (25); a blast volume (VI) including a piston (12) which moves on contact separation and urges compressed gas through a blast nozzle (7) which opens over the zone where a main arc forms when the arc contacts separate, and a set of auxiliary contacts (22a, 21c) in series with the arc contacts for creating an auxiliary arc in the volume (V2) situated behind the piston, the circuit breaker further including means (23, 24) for allowing the auxiliary contacts to separate only when the pressure in the blast zone reaches a predetermined threshold.
Patent DE-3875867-T2 (DE)
Inventor: JACOBS STEPHEN ALLEN
IPC: A61K31/19
Filed: 1988-08-15
Granted: 1993-04-01
Abstract: A calcium citrate malate complex or mixture having a molar composition of calcium:citrate:malate of about 6:2:3. The calcium citrate malate is preferably administered in an oral dosage form, containing pharmaceutically-acceptable carriers and excipients.
Patent TR-199901853-T2 (TR)
Inventor: JONATHAN BRIAN HAUPTMAN
IPC: A61K38/00
Filed: 1998-01-29
Abstract: Gastrointestinal lipaz inhibitörünün 11. tip diabetes mellitusun engellenmesi veya tedavisi için oral ilaçlarin üretimi için kullanilmasindan ve üretilen ilaçlardan ibarettir.
Patent DE-60001917-T2 (DE)
Inventor: EVANS RICHARD
IPC: H02G15/00
Filed: 2000-01-07
Granted: 2004-01-29
Abstract: A termination for an electrical power cable (1) includes a load carrying conductor (2), the termination comprising an insulating outer member (5) through which the load carrying conductor, or an extension of it, runs substantially longitudinally, and means (11) for controlling electrical stress concentrations within the outer member. Residual space (13) within the outer member is occupied by electrically insulating solid granules and interstices between the granules are filled with electrically insulating fluid. Suitably chosen granules may have better thermal conductivity, lower thermal expansion coefficient and lower cost than the fluid that might otherwise occupy the whole of the residual space, and granules are cheaper and more versatile than moulded bodies.